These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20186334)

  • 21. Evidence for diabetes-induced alterations in the sulfation of heparin sulfate intestinal epithelial cells.
    Lévy P; Picard J; Bruel A
    Life Sci; 1984 Dec; 35(26):2613-20. PubMed ID: 6239964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparan sulfate structure in mice with genetically modified heparan sulfate production.
    Ledin J; Staatz W; Li JP; Götte M; Selleck S; Kjellén L; Spillmann D
    J Biol Chem; 2004 Oct; 279(41):42732-41. PubMed ID: 15292174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase.
    Robinson CJ; Mulloy B; Gallagher JT; Stringer SE
    J Biol Chem; 2006 Jan; 281(3):1731-40. PubMed ID: 16258170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simplified and sensitive fluorescent method for disaccharide analysis of both heparan sulfate and chondroitin/dermatan sulfates from biological samples.
    Deakin JA; Lyon M
    Glycobiology; 2008 Jun; 18(6):483-91. PubMed ID: 18378523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Degradation of heparan sulfate with heparin lyases.
    LeBrun LA; Linhardt RJ
    Methods Mol Biol; 2001; 171():353-61. PubMed ID: 11450249
    [No Abstract]   [Full Text] [Related]  

  • 26. Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche.
    Gupta P; Oegema TR; Brazil JJ; Dudek AZ; Slungaard A; Verfaillie CM
    Blood; 1998 Dec; 92(12):4641-51. PubMed ID: 9845530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The degree of polymerization and sulfation patterns in heparan sulfate are critical determinants of cytomegalovirus entry into host cells.
    Mitra D; Hasan MH; Bates JT; Bierdeman MA; Ederer DR; Parmar RC; Fassero LA; Liang Q; Qiu H; Tiwari V; Zhang F; Linhardt RJ; Sharp JS; Wang L; Tandon R
    PLoS Pathog; 2021 Aug; 17(8):e1009803. PubMed ID: 34352038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparable stabilisation, structural changes and activities can be induced in FGF by a variety of HS and non-GAG analogues: implications for sequence-activity relationships.
    Rudd TR; Uniewicz KA; Ori A; Guimond SE; Skidmore MA; Gaudesi D; Xu R; Turnbull JE; Guerrini M; Torri G; Siligardi G; Wilkinson MC; Fernig DG; Yates EA
    Org Biomol Chem; 2010 Dec; 8(23):5390-7. PubMed ID: 20865198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging Glycosaminoglycan Modification Patterns In Vivo.
    Bülow HE
    Methods Mol Biol; 2022; 2303():539-557. PubMed ID: 34626406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expedient Synthesis of Core Disaccharide Building Blocks from Natural Polysaccharides for Heparan Sulfate Oligosaccharide Assembly.
    Pawar NJ; Wang L; Higo T; Bhattacharya C; Kancharla PK; Zhang F; Baryal K; Huo CX; Liu J; Linhardt RJ; Huang X; Hsieh-Wilson LC
    Angew Chem Int Ed Engl; 2019 Dec; 58(51):18577-18583. PubMed ID: 31553820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequence analysis of heparan sulphate and heparin oligosaccharides.
    Vivès RR; Pye DA; Salmivirta M; Hopwood JJ; Lindahl U; Gallagher JT
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):767-73. PubMed ID: 10215618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dromedary glycosaminoglycans: molecular characterization of camel lung and liver heparan sulfate.
    Warda M; Linhardt RJ
    Comp Biochem Physiol B Biochem Mol Biol; 2006 Jan; 143(1):37-43. PubMed ID: 16298150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Docking glycosaminoglycans to proteins: analysis of solvent inclusion.
    Samsonov SA; Teyra J; Pisabarro MT
    J Comput Aided Mol Des; 2011 May; 25(5):477-89. PubMed ID: 21597992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzymatic preparation of heparin disaccharides as building blocks in glycosaminoglycan synthesis.
    Kim YS; Thanawiroon C; Bazin HG; Kerns RJ; Linhard RJ
    Prep Biochem Biotechnol; 2001 May; 31(2):113-24. PubMed ID: 11426699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of heparan sulfate 6-O-sulfotransferases in human embryonic kidney 293 cells results in increased N-acetylglucosaminyl 6-O-sulfation.
    Do AT; Smeds E; Spillmann D; Kusche-Gullberg M
    J Biol Chem; 2006 Mar; 281(9):5348-56. PubMed ID: 16326709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization and functional characterization of glycosaminoglycan domains in the normal human kidney as revealed by phage display-derived single chain antibodies.
    Lensen JF; Rops AL; Wijnhoven TJ; Hafmans T; Feitz WF; Oosterwijk E; Banas B; Bindels RJ; van den Heuvel LP; van der Vlag J; Berden JH; van Kuppevelt TH
    J Am Soc Nephrol; 2005 May; 16(5):1279-88. PubMed ID: 15788473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. By-Products of Heparin Production Provide a Diverse Source of Heparin-like and Heparan Sulfate Glycosaminoglycans.
    Taylor SL; Hogwood J; Guo W; Yates EA; Turnbull JE
    Sci Rep; 2019 Feb; 9(1):2679. PubMed ID: 30804383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping critical biological motifs and biosynthetic pathways of heparan sulfate.
    Lawrence R; Kuberan B; Lech M; Beeler DL; Rosenberg RD
    Glycobiology; 2004 May; 14(5):467-79. PubMed ID: 15033939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymic epithelial cells synthesize a heparan sulfate with a highly sulfated region.
    Werneck CC; Oliveira-Dos-Santos AJ; Silva LC; Villa-Verde DM; Savino W; Mourão PA
    J Cell Physiol; 1999 Jan; 178(1):51-62. PubMed ID: 9886490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites.
    Goger B; Halden Y; Rek A; Mösl R; Pye D; Gallagher J; Kungl AJ
    Biochemistry; 2002 Feb; 41(5):1640-6. PubMed ID: 11814358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.